Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mpower versus plain minoxidil in androgenetic alopecia
ISRCTN65325698Phase 4Completed
- Sponsor
- Zydus Lifesciences Limited
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Zydus Lifesciences Limited. Primary endpoints: Hair diameter at 4 months, Terminal hair density at 4 months and 2 more. Started Sep 2023; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ISRCTN65325698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN65325698.